Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Guiot (Liège, Belgium), M. Henket (Liège, Belgium), B. André (Liège, Belgium), N. Hardat (Namur, Belgium), M. Herzog (Namur, Belgium), M. Njock (Liège, Belgium), M. Malaise (Liège, Belgium), R. Louis (Liège, Belgium). Levels of IGFBP-1, MMP-9 and circulating nucleosomes: a new model to diagnose SSc-ILD. 798

Member's Comments

No comment yet.

Related content which might interest you: Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes? Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease? Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Significance of serum YKL-40, S100A8, S100A9, calprotectin, periostin and LRG1 levels in patients with newly diagnosed, controlled and uncontrolled asthma Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 YKL-40, soluble IL-2 receptor, ADA and neopterin: comparison of markers of sarcoidosis activity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients Source: Eur Respir J 2015; 45: 1482-1485 Year: 2015 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Evaluation of CCL18 serum levels and genetic variant as prognostic biomarkers in SSc-ILD Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004 Circulating eNAMPT and resistin as emerging biomarkers in sepsis Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 High serum levels of YKL-40 in IPF Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Characterisation of asthma subgroups associated with circulating YKL-40 levels Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017 Year: 2017 TNF-alpha, IL-8, IL-6 levels in serum of sarcoidosis patients with different clinical course Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Plasma levels of TIPM-2 in patients with COPD Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 PP231 – Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: ERS Lung Science Conference 2021 Year: 2021